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ABSTRACT 
Suspension  cultures  of neoplastic  mouse  mast  cells  were  used  to  obtain  large 
quantities of a homogeneous cell population as starting material for cell fractiona- 
tion.  A  Golgi  fraction  was  prepared  by slight  modification  of established  tech- 
niques  and  identified  by  electron  microscopy.  Assay  of galactosyl  transferase 
activity using ovalbumin,  desialylated  degalactosylated orosomucoid, and N-ace- 
tylglucosamine as galactose acceptors showed that the Golgi fraction was enriched 
in  specific  activity  over  the  homogenate.  The  Golgi  galactosyl  transferase  was 
examined  in detail.  Acceptor concentrations for optimal galactose incorporation 
were determined, and substrate inhibition effects were shown with higher concen- 
trations of all three acceptors. Manganese was shown to be necessary for galactose 
incorporation.  A  higher  concentration  of manganese  afforded  some  protection 
from substrate  inhibition by acceptors, but at the same time was itself inhibitory. 
All  three  acceptors  competed  with  one  another  for  galactose  incorporation, 
indicating that a single enzyme catalyzed the transfer of galactose for all acceptors. 
Formation of the carbohydrate portion of glyco- 
proteins involves the sequential addition of sugars 
onto a protein core. The subcellular site for addi- 
tion  of at  least  some  of these  sugars  has  been 
localized to the Golgi apparatus  (20, 24), and in 
particular, the transfer of galactose to glycoprotein 
has been examined with this organelle. Galactose 
transfer  to  glycoprotein or N-acetylglucosamine 
(5,  6,  10,  15)  is now considered to be  the  best 
marker for the Golgi apparatus, at least in tissues 
such as liver that produce glycoprotein primarily 
for export. Although transfer to N-acetylglucosa- 
mine  has been shown with  milk  enzyme (21)  to 
reflect the same enzymatic activity as transfer of 
galactose to glycoproteins, this identity for Golgi 
fractions has not been fully established. 
Golgi fractions from whole tissues such as liver 
(5, 6, 10, 16, 20, 24), pancreas (19), kidney (7), 
or testis (4), represent preparations derived from a 
heterogeneous mixture of cells, including diverse 
connective tissue elements in addition to the ma- 
jor functional cells of the organ. Thus, even those 
fractions  composed  largely  of  Golgi  elements 
would contain Golgi material derived from several 
different  cell  types,  and  the  metabolic  activities 
(such as galactosyl transferase) ~ of these fractions 
could not be ascribed with certainty to the Golgi 
apparatus of any one particular cell.  In order to 
The term galactosyl transferase in this paper refers to 
UDP-galactose: N-acetylglucosaminide galactosyl trans- 
ferase. 
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tus  of  a  specific  cell  type  by  fractionation  tech- 
niques, a pure population of cells would be advan- 
tageous. 
The  growth  of large  volumes of cells  in  tissue 
culture provides a  convenient means of obtaining 
homogeneous cell populations for subsequent cell 
fractionation.  We  have  prepared  an  enriched 
Golgi fraction from a  population of cultured neo- 
plastic mast cells,  2 and have studied the galactosyl 
transferase of this Golgi fraction. These cells were 
chosen  because  they  offer  several  advantages  in 
growth characteristics and also display interesting 
facets of specialized metabolism (8). The cells can 
be grown in large  volume  suspension cultures so 
that gram quantities can be obtained free of extra- 
cellular material (13). 
MATERIALS  AND  METHODS 
Cell Sources and Growth Conditions 
Cells  originally  derived  from  a  solid  Dunn-Potter 
P815 mouse mastocytoma have been carried in this labo- 
ratory for several years  (12).  Maintenance of cell cul- 
tures and techniques for production in large volume have 
been described (12, 13). Harvests on a single run have 
been as high as  14 ml of packed cells from a  12-liter 
spinner culture. 
Incorporation of [3H]leucine  by the growing cells was 
used  to  label  cell  protein,  allowing  assay  of  the  3H- 
protein radioactivity in the various subcellular fractions. 
For this purpose a relatively small volume of ceils was 
labeled by growth for 3-4 days in separate 250-ml cul- 
tures with the addition of [3H]leucine  (0.2 mC/250 ml) 
to the medium. These cells were collected, washed sev- 
eral times, and pooled with the larger cell harvest just 
before homogenization. 
Fractionation Procedure 
Several established methods for preparing liver Golgi 
fractions were first attempted on the cultured cell sys- 
tem.  When the fractionation methods of Morr6 et al. 
(16), Leelavathi et al. (10), and Fleischer and Fleischer 
(6) were each applied individually and essentially with- 
out modification, the Golgi fractions obtained were of 
low yield and appeared to be highly contaminated with 
other cell material. The technique ultimately devised to 
yield the highest recovery and purity of the Golgi frac- 
tion represented a combined version of these methods. 
All fractionation procedures were conducted at 4~ 
For  a  typical  experiment,  4-8  ml  of  packed  cells 
(including [aH]leucine-labeled cells) were suspended to- 
2 A  preliminary  communication  has  been  published 
which includes the  preparation and  use  of this  Golgi 
fraction (8). 
gether in 1 vol of a homogenization medium composed 
of 0.5 M sucrose in 0.1 M potassium phosphate buffer, 
pH 6.65, plus 0.005  M MgCI2. All subsequent sucrose 
gradient solutions were made in this same buffer. The 
viscous suspension was transferred to a tight-fitting glass 
Dounce homogenizer (Kontes Company, Vineland, N. 
J.), and the cells were disrupted with 40-50 strokes. The 
progress of homogenization was assessed by phase-con- 
trast microscopy. The homogenate was then centrifuged 
for 10-15 min at 2,000 g (Sorvall RC2-B centrifuge, SS- 
34  rotor  ]Du  Pont  Instruments,  Sorvall  Operations, 
Newtown, Conn.]), resulting in a cloudy supernate and a 
dense pellet. The yellowish upper one-tenth of the pellet 
(designated by Morr6 et al.  [16]  as the  "Golgi-rich" 
region in liver fractionation procedures) was  aspirated 
and combined with the entire 2,000 g  supernate. The 
resulting suspension was diluted by an equal volume of 
homogenization medium, and 4-ml portions were then 
layered over discontinuous gradients composed of 4.0 ml 
each of 1.7 M  and 2.1  M  sucrose solutions in 12.5-ml 
cellulose nitrate centrifuge tubes. These gradients were 
centrifuged for 60 min at 105,000 g  (Beckman L2-75B 
ultracentrifuge,  SW-41  rotor;  Beckman  Instruments, 
Inc.,  Spinco  Div.,  Palo  Alto,  Calif.)  to  form  a  two- 
layered band at the 0.5 M:l.7 M interface and a single 
band at the 1.7 M'2.1 M interface. The yellowish upper 
layer of  the  band  at  the  0.5  M:l.7  M  interface was 
aspirated  separately  and  designated  as  "'membrane 
fraction 1". This was used to prepare the "Golgi" and 
"mixed  membrane"  pellets.  The  lower  layer  of  this 
band was pooled with the entire band at the 1.7 M:2.1 
M  interface and was  designated "membrane fraction 
2". Although the latter fraction was used for correlated 
experiments,  it  was  not  fractionated  further.  Mem- 
brane fraction 1 was then adjusted to 1.1 M in sucrose 
and was diluted by the addition of 1 or 2 vol of a 1.1 M 
sucrose solution. Portions of this fraction (4 ml each) 
were layered over 4 ml of 1.5 M sucrose, followed by 
4  ml of homogenizing medium  in  12.5-ml centrifuge 
tubes.  The  resulting  gradients  were  centrifuged  at 
105,000 g  for 90  min to  form  a  "Golgi" band (0.5 
M:I.1  M  interface)  and  a  "mixed  membrane"  band 
(1.1  M:l.5 M interface). These bands were aspirated, 
suspended in homogenizing medium, and pelleted by 
centrifugation at  105,000 g  for  30  min.  Portions  of 
each  pellet  were  processed  for electron  microscopy, 
and the remaining portions were used for determina- 
tion of protein content and enzyme activity. 
Electron  Microscopy 
Whole cells or pelleted cell fractions were fixed 2-4 h 
in a solution of 2.0% glutaraldehyde (Polysciences, Inc., 
Warrington, Pa.) in 0.05 M  phosphate buffer, pH 7.2, 
washed overnight in 0.1 M phosphate buffer plus 0.2 M 
sucrose, pH 7.2, and post-fixed in 1.0% OsO4 in 0.1 M 
phosphate buffer, pH 7.2, 1-2 h. Specimens were dehy- 
drated in ascending grades of ethanol and finally infil- 
trated and embedded in Spurr (Polysciences, Inc.). 
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cells were stained with uranyl acetate (25)  and  lead 
citrate (18). For negative staining, a small aliquot (0.05- 
0.1 ml) of the Golgi band was suspended for 1-2 min in 
1-2 drops of 2.0% phosphotungstic acid at pH 6.8 over 
parlodion-coated grids. All specimens were examined 
and photographed on a Phillips EM-300 electron micro- 
scope. 
Analytical Procedures 
Protein content of the  homogenate and the various 
fractions was assayed by the Lowry procedure (14) and 
by determination of the amount of [aH]leucine-labeled 
protein. 
Galactosyl transferase assays were performed  with 
two  different glycoproteins and  a  monosaccharide as 
[14C]galactose acceptors. Incubation mixtures contained 
the following  ingredients in a total volume of 0.025 ml: 
0.05  M 2-(N-morpholino)ethane sulfonic acid (MES) 
buffer, pH 6.5, (Calbiochem, San Diego, Calif.); 0.01 
M MnCI~; 0.1%  Triton  X-100 (Fisher Scientific Co., 
Pittsburgh, Pa.);  0.0007 M UDPp4C]galactose, 2.5  x 
105 cpm (New England Nuclear Corp., Boston, Mass.); 
0.001-0.008  ml of cell homogenate or subcellular frac- 
tion plus one of the following acceptors: (a) 0.25  mg 
ovalbumin (Sigma Chemical Co., St. Louis, Mo.); (b) 
0.05 mg desialylated, degalactosylated orosomucoid  s (a 
generous  gift of  Dr.  H.  Schachter, University  of 
Toronto, Toronto,  Ont.); (c) 0.02 M N-acetylglucosa- 
mine (Calbiochem). 
The incubation mixtures for the measurement of 5'- 
nucleotidase activity contained the above MES buffer, 
MnCI2, Triton X-100, and aliquots of homogenate or 
subcellular fraction in the same concentrations as in the 
galactosyl transferase assays with the addition of 0.0008 
M [all]AMP,  1.7  x  l& cpm, (New England Nuclear 
Corp.).  It was possible to assay 5'-nucleotidase in the 
same reaction mixtures used for the ovalbumin or oroso- 
mucoid galactosyl transferase assay as  previously de- 
scribed (9). 
Reaction mixtures for both assays were incubated at 
37~  and at 15 min and 45 min, 0.005-ml aliquots were 
removed  and  spotted  on  Whatman  #1  filter  paper 
(VWR Scientific  Div. Univar, San Francisco, Calif.) and 
chromatographed in ethanol:l M ammonium acetate, 
pH 7.8 (5:2), as previously described (9). Appropriate 
radioactive areas of the chromatogram were assayed for 
determination of galactose transfer and adenosine for- 
mation (9). Various permutations and combinations of 
acceptors  and  components  were used  in  assays in- 
vestigating pH  optimum,  cofactor requirements,  sub- 
strate  concentration  optima,  and  competition  for 
galactose transfer. 
3 The term orosomucoid in this paper refers to desialyl- 
ated, degalactosylated orosomucoid. 
RESULTS 
Morphology and Fractionation 
Low magnification electron microscopy (Fig. 1) 
revealed  that  the  size,  shape,  and  nucleocyto- 
plasmic ratio of the cultured cells were similar to 
those of normal mast cells, but there was an ab- 
sence of cytoplasmic storage  granules. This was 
consistent with the known loss of heparin-produc- 
ing ability by this particular line of cultured cells 
(12). Mitochondria were present as were several 
structures representing secondary lysosomes. Al- 
though the rough endoplasmic reticulum was dis- 
tributed only sparsely  as  branching tubules and 
cisternae, there  was  an abundance of free  ribo- 
somes throughout the cytoplasm. (Aggregates of 
these free ribosomes proved to be a  major con- 
taminant during the initial attempts at isolation of 
a  Golgi  fraction.)  The  Golgi  apparatus  usually 
appeared as stacks or irregular arrays of cisternae 
in the cell center, relatively close to the nucleus. 
Electron  microscopy  of  the  Golgi  fraction  is 
shown in Fig. 2, which represents a  typical field 
from upper, middle, or lower levels of the Golgi 
pellet.  Membranous structures present  included 
what appeared to be cross-sections through stacks 
of curved, parallel Golgi cisternae (10, 16). Much 
of the remaining field contained membranous ele- 
ments which may represent cisternae sectioned in 
other planes, plus some  membranous fragments 
derived from  plasma membrane. Fields at  both 
low  and  high  magnification appeared  indistin- 
guishable from  similar published views  of  liver 
Golgi fractions (16). 
Negatively-stained Golgi elements (Fig. 3) re- 
sembled comparable structures from negatively- 
stained  liver  Golgi  fractions  (16).  The  fraction 
designated  mixed  membranes  appeared  to  be 
composed  of  rough  endoplasmic  reticulum, 
plasma membrane, and some free ribosomes. 
Representative values for the protein content of 
the  homogenate  and  the  various  fractions  are 
shown in Table I. Routinely, protein values deter- 
mined by the technique of Lowry were compared 
with 3H-protein assays in order to calculate a value 
representing the  3H-protein cpm/mg protein for 
the homogenate. Protein recovery in the various 
fractions was  then calculated by dividing the 3H- 
protein assay values by the figure for 3H-protein 
cpm/mg protein of the  homogenate. In order to 
preserve  fraction material, Lowry protein deter- 
minations were not performed routinely on all the 
fractions. When performed, the Lowry determina- 
FREILICH, LEWIS, REPPUCCI, AND  SILIIERT Galactosyl  Transferase  657 FIGURE  1  Cultured neoplastic mast cell. Mitochondria (M) show a normal morphology and distribution. 
Cisternae of the rough endoplasmic reticulum  (RER) are relatively  sparse while close inspection reveals 
abundance of free ribosomes throughout the cytoplasm. Portions of the Golgi apparatus (G) in this cell 
appear as irregular groups of cisternae, x  24,500. 
658  THE  JOURNAL OF  CELL BIOLOGY" VOLUME 72,  1977 Fmu~ 2  Section  from a typical Golgi pellet. The field contains many small Golgi stacks (GS) consisting 
of several parallel cisternae. In addition, there are numerous single Golgi cisternae (GC) throughout the 
field. The irregular membrane-bounded spaces (X) seen adjacent to many Golgi cisternae represent 
dilations of individual cisternae,  x  19,000. Inset shows higher magnification of a Golgi stack (double 
arrows) from a neighboring field, x  33,000. 
tions were similar to those derived by the above 
method. 
The  recovery  of  protein  in  the  Golgi  pellet 
amounted to approx. 0.4% of the total homoge- 
nate protein. This is somewhat less than the usual 
yield for  Golgi fractions isolated from  liver (1, 
10).  However,  it  should  be  noted  that,  in  the 
present procedure, only the upper portion of the 
band at the  0.5  M:l.7 M  interface was used to 
prepare the final Golgi fraction so that the yield of 
Golgi particles was sacrificed for the sake of frac- 
tion purity. 
Enzyme Activities 
Table I shows the results of galactosyl transfer- 
ase assays performed after a typical fractionation 
procedure. Assays with each of the three different 
acceptors were performed on fractions from a sin- 
gle preparation, although each set of assays with 
any one of the acceptor types was carried out on 
separate days. The 15-min and 45-min samples of 
all  assays  indicated  that  the  incorporation  of 
["C]galactose into the various acceptors under our 
conditions was  linear within  this  time  interval. 
Routinely, four or more concentrations of Golgi 
preparation and two  concentrations of homoge- 
nate  were  utilized in the  assays.  Incorporations 
were  always proportional to the  sample 3H-pro- 
tein. Two concentrations  of the other cell fractions 
were utilized on occasion. Activities were always 
FREILICH, LEWIS, REPPUCCI, AND  SILBERT  Galactosyl Transferase  659 FIGURE 3  Golgi fraction, negatively stained.  Flattened, platelike Golgi cisternae (GC) of various sizes 
display attached peripheral tubules which in one area (double arrow) connect adjacent cisternae. Certain 
cisternae show evidence of possible intracisternal channels (single arrows), although this appearance could 
he due to shrinkage or staining effects,  x  60,000. 
proportional to  protein.  In  this  experiment  the 
specific  activity of  galactosyl transferase  in  the 
Golgi pellet showed an enrichment of 11- to 14- 
fold over membrane  fraction  1 with all acceptor 
types.  Enrichments  over  homogenate  were  less 
consistent, due to problems in sampling related to 
viscosity of the homogenate. Ovalbumin was the 
acceptor employed after most fractionation proce- 
dures, and the specific activity of galactosyl trans- 
ferase of four other Golgi preparations was 35-50 
times that  of the  homogenate.  As noted  previ- 
ously,  recoveries were  limited  by  a  sacrifice  of 
Golgi protein to  permit isolation of a  relatively 
pure fraction. In this regard, the assay employing 
ovalbumin indicated that as much as 25%  of the 
total  homogenate  galactosyl transferase  activity 
was  located in  membrane  fraction 2,  which  was 
not further  utilized for preparation of the  Golgi 
fraction. The  specific activity of galactosyi trans- 
ferase was not enriched in the mixed membrane 
fraction,  suggesting  that  galactosyl  transferase 
may  be  a  specific  Golgi-marker enzyme  in  this 
cell type. 
The results of the 5'-nucleotidase assays are also 
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Galactosyl Tranaferase and 5'-Nucleotidase Activities 
Cell preparation 
Fraction  Total Protein 
p4C]Galactose incorporation into acceptors  [all]Adenosine formed 
Ovalbumin*  Orosomucoid  N-Acetyllactosamine 
Protein  Total  Protein  Total  Protein  Total  Protein  Total 
Homogenate 
2,000 g  supernate 
Membrane fraction 
1 
2 
Pellets 
Golgi 
Mixed membrane 
mg  lamol/rag  p,  mol  praollmg  ~rnol  imwl/mg  pmol  ~mol/mg  ~rnol 
1,540  0.0017  2.56  0.012  17.7  0.012  17.7  0.014  21.6 
985  0.0021  2.05  --  -  0.013  12.8  0.014  13.8 
153  0.011  1.60  0.039  5.9  0.047  7.2  0.012  1.8 
390  0.0017  0.65  ....  0.017  6.6 
6  0.155  0.95  0.430  2.5  0.600  3.6  0.190  1.1 
4  0.0038  0.02  -  -  0.013  0.15  0.100  0.4 
* These assays were performed with an ovalbumin concentration less than maximal; total amounts incorporated are lower than can be optimally achieved with 
this acceptor. 
shown  in  Table  I.  The  Golgi  pellet  contained 
about 5 % of the total homogenate 5'-nucleotidase 
activity and showed an increase in specific activity 
of about  13-fold over the  homogenate. The  5'- 
nucleotidase enrichment in the mixed membrane 
pellet was about one-half that of the Golgi pellet, 
probably reflecting a  proportion of rough endo- 
plasmic reticulum and free ribosomes greater than 
plasma membranes in this fraction. 
Characteristics of Galactosyl  Transferase 
Galactosyl transferase activity with ovalbumin 
as  the  acceptor  had  an  absolute manganese re- 
quirement which  could  not  be  satisfied  by  the 
substitution of magnesium. Omission of Triton X- 
100 resulted in a 75% loss of activity. Incorpora- 
tion into endogenous material was too low to be 
measurable, so that omission of ovalbumin essen- 
tially eliminated incorporation. The pH optimum 
for  ["C]galactose  incorporation into  ovalbumin 
was at pH 6.5, with approx. 50% of the activity 
remaining at pH 5.5 and 8.0. 
Incorporation of  ["C]galactose  with orosomu- 
coid, ovalbumin, and N-acetylglucosamine as ac- 
ceptors over a range of acceptor concentrations is 
shown in Fig. 4. There was a sharp maximum for 
orosomucoid and N-acetylglucosamine as  accep- 
tors and a rapid falling off of incorporation with 
higher acceptor concentrations. This was particu- 
larly marked in the case of orosomucoid. Ovalbu- 
min  also  appeared  to  be  a  poorer  acceptor  at 
higher concentrations, but the decrease in incor- 
poration was minimal. This orosomucoid prepara- 
tion contained 0.4 /~mol of terminal N-acetylglu- 
cosamine per milligram (H.  Schachter; personal 
0  tO  20  50  40  50  60 
,4CCEPTOR [mg/mll 
FIGURE 4  Incorporation  of  p4C]galactose at  varying 
acceptor concentrations. Incubation mixtures contained 
the following  in a total vol of 0.025 mh 0.05 M MES (pH 
6.5);  0.01 M MnCI~; 0.1%  Triton X-100; 0.0007  M 
UDp[14C]galactose (2.5 x 10  ~  cpm); 0.0012 mg of Goigi 
fraction; plus either (a) ovalbumin, &; (b) orosomucoid, 
O; or (c) N-acetylglucosamine,  II. Incubation and assay 
were carded out as described in Materials and Methods. 
Results show incorporation with a 0.005-ml aliquot after 
45-min incubation at 37~ 
communication). From this, the concentration of 
terminal N-acetylglucosamine acceptor  at  the  2 
mg/ml  concentration  needed  for  maximum 
[t4C]galactose  incorporation can be calculated to 
be 0.0008 M. The peak of p4C]galactose  incorpo- 
ration with free N-acetylglucosamine as acceptor 
occurred at 3.3 mg/ml which is equal to 0.015 M, 
a  much  higher  concentration. The  terminal N- 
acetylglucosamine content of ovalbumin has been 
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than that of orosomucoid. From this, the concen- 
tration of acceptor N-acetylglucosamine at maxi- 
mal [t4C]galactose  incorporation (20 mg/ml oval- 
bumin) can  be  calculated  as  0.0004-0.001  M. 
When Km  values  were  estimated  by  reciprocal 
plots, the value for orosomucoid was 3.5  x  10 -4 
M  while  that  for  the  free  N-acetylglucosamine 
acceptor was 12 x  10  -4 M. The K,, for ovalbumin 
was  8  mg/ml  or  approx.  1.6-4  x  10 -4  M  for  .~ 
hexosamine acceptor.  These K,~  values must be  ,~  1,500 
considered to be approximate because of the inde- 
terminate degree of substrate inhibition at lower  ~ 
substrate  concentrations. In  any  case,  it  would  ~  1,000 
appear  that orosomucoid (and probably ovalbu- 
min as  well) is  a  better galactose  acceptor than 
free N-acetylglucosamine. Even though the maxi- 
mum amount of [14C]galactose incorporation with 
free N-acetylglucosamine as acceptor was higher,  ~  500 
substrate  inhibition by  orosomucoid  was  much  ~ 
more marked, and it is probable that this inhibi- 
tion prevented a higher [14C]galactose incorpora- 
tion by orosomucoid. 
On  several  occasions,  a  14C-labeled  origin 
(after incubation of UDP[~4C]galactose  with oro- 
somucoid  or  ovalbumin) was  incubated with  a 
highly  specific  fl-galactosidase  from  Charonia 
lampus  (Miles Laboratories Inc., Miles Research 
Products, Kankakee, Ill.). This treatment quantita- 
tively released ~4C-radioactivity,  while incubation 
of ~4C-labeled origins in similar mixtures lacking 
/3-galactosidase  resulted in less than 5% release of 
radioactivity. The radioactivity released by fl-ga-  ~  ~oo- 
lactosidase chromatographed as a monosaccharide  ~: 
on Sephadex G-10. The ~4C-labeled material chro- 
matographing in the N-acetyllactosamine area was 
also incubated with fl-galactosidase. Before incu-  ~  I9oo 
bation, it chromatographed as a  disaccharide on 
Sephadex G-10, while after/3-galactosidase treat- 
ment the radioactivity chromatographed as a mon-  '~ 
"~  500  osaccharide. 
The  effects  of  manganese  concentration  on  ~ 
[~4C]galactose incorporation into orosomucoid at  '~ 
optimal (2 mg/ml) and inhibitory (10 mg/ml) con- 
centrations of orosomucoid are shown in Fig. 5. 
At  optimal  orosomucoid  concentration,  man- 
ganese was inhibitory at a  concentration greater 
than 0.01 M. In contrast, when inhibitory levels of 
orosomucoid (10 mg/ml) were used, higher con- 
centrations of MnC12 became necessary for opti- 
mal activity. 
In order to investigate the effects  of manganese 
further,  the  incorporation of  [~4C]galactose  into 
varying concentrations of orosomucoid was exam- 
ined at several manganese concentrations (Fig. 6). 
At 0.1  M manganese concentration, there was a 
slight shift to a higher orosomucoid concentration 
for maximum incorporation and a partial protec- 
tion from inhibitory effects of the higher orosomu- 
coid concentration. At still higher manganese lev- 
els  (0.3  M  MnC12), there  appeared  to  be  even 
I  ]  L 
01  02  03 
Mn C/e [/14/ 
FIOURE 5  The effects of manganese on [~*C]galactose 
incorporation. Incubation and assay were carried out as 
described in Fig. 4  with MES  buffer, Triton  X-100, 
UDP[14C]galactose, and Golgi fraction, plus MnCl=  as 
indicated, and orosomucoid 2 mg/ml, O, and 10 mg/ml, 
￿9 
v 
2  4  6  8  tO 
OROSOMUCO/D  [ mg/m/.l 
Incorporation of [14C]galactose into varying  FIGURE  6 
concentrations of  orosomucoid at  varying manganese 
concentrations. Incubation and assay were carried out as 
described in  Fig. 4  with MES  buffer, Triton  )(-100, 
UDP[14C]galactose, and Golgi fraction, plus orosmu- 
cold as indicated, and 0.01 M MnCl~;  Q; 0.1 M MnCI2, 
￿9  0.3 M MnCl2, ~7. 
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should be noted, however, that despite the protec- 
tion  from  orosomucoid  substrate  inhibition  af- 
forded  by manganese,  the  maximum  [14C]galac- 
tose incorporation at  noninhibitory orosomucoid 
concentrations  was  less  with  increasing  MnCI2 
concentrations. Thus, the MnClz itself seemed to 
be inhibitory at higher concentrations at the same 
time  that  it  partially  reversed  the  orosomucoid 
substrate inhibition. 
Incorporation  of  [14C]galactose  into  varying 
concentrations of orosomucoid in the absence and 
presence  of N-acetylglucosamine  (0.005  M)  is 
shown  in  Fig.  7.  N-acetylglucosamine  inhibited 
incorporation of galactose into orosomucoid. Fur- 
thermore,  incorporation of galactose into N-ace- 
tyllactosamine  was  markedly  reduced  with  in- 
creasing concentrations of orosomucoid. The two 
substrates would thus appear to be mutually com- 
petitive.  However,  problems regarding substrate 
inhibition  (Fig. 4) immensely complicate any de- 
tailed  analysis of the  kinetics  of these  reactions. 
Incorporation of [~4C]galactose into ovalbumin in 
the absence and presence of N-acetylglucosamine 
(0.005 M) is shown in Fig. 8. The competition was 
similar to that seen with orosomucoid. Incorpora- 
tion of [~4C]galactose with varying concentrations 
of N-acetylglucosamine as acceptor in the absence 
and presence of orosomucoid (2 mg/ml) is shown 
I  2Doo 
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FIGURE  7 
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Effect of N-acetylglucosamine on the incor- 
poration of [~4C]galactose  into orosomucoid. Incubation 
and assay were as described in Fig. 4 with MES buffer, 
MnCl2, Triton  X-100,  UDP[~4C]galactose, and  Golgi 
fraction, plus orosomucoid as indicated, with or without 
N-acetyiglucosamine. Incorporation  into  orosomucoid 
without N-acetylglucosamine, O, with 0.005 M N-acetyi- 
glucosamine, O, incorporation into N-acetyllactosamine, 
I-7. 
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FI~U~  8  Effect of N-acetylglucosamine on the incor- 
poration of  [~4C]galactose into ovalburnin.  Incubation 
and assay were as described in Fig. 4 with MES buffer, 
MnCI=,  Triton  X-100,  UDP[14C]galactose,  and  Golgi 
fraction, plus ovalbumin as indicated, with or without 
N-acetylglucosamine.  Incorporation  into  ovalbumin 
without  N-acetylglucosamine,  &,  with  0.005  M  N- 
acetylglucosarnine,  A,  incorporation  into  N-acetyl- 
lactosamine, [2. 
in  Fig.  9.  Orosomucoid  inhibited  incorporation 
into N-acetyllactosamine,  and  incorporation  into 
orosomucoid was markedly reduced with increas- 
ing N-acetylglucosamine concentrations.  The  re- 
suits  obtained  using  ovalbumin  (20  mg/ml)  in 
place of orosomucoid were essentially the same. 
Here again, either of the two glycoprotein accep- 
tors and N-acetylglucosamine was mutually inhibi- 
tory. When orosomucoid and ovalbumin were uti- 
lized together in the same incubation mixture (Ta- 
ble II), the incorporation of []aC]galactose into the 
two acceptors was not additive, implying that the 
transfer  of galactose  to  both  glycoproteins  was 
catalyzed by the same enzyme. 
DISCUSSION 
The results of this study indicate that fractionation 
techniques previously applied to solid tissues can 
be  applied  with  modification  for  successful  use 
with  a  cultured  cell  system.  The  recovery of an 
enriched Golgi fraction was confirmed by electron 
microscopy, the elements composing the fraction 
being quite similar in appearance to Golgi prepa- 
rations  isolated  from liver,  the  tissue  used  most 
widely  for the  isolation  of Golgi  fractions.  The 
density  and  sedimentation  characteristics  of the 
Golgi apparatus  from these  neoplastic mast cells 
must  also be  quite  similar  to that  of liver  Golgi 
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densities used to obtain the Golgi preparations in 
the  present  study  were  essentially  identical  to 
those used in studies on liver tissue. 
As  with  the  Golgi  apparatus  prepared  from 
solid tissues, the Golgi fraction from the cultured 
mast cells  was enriched  in galactosyl transferase 
activity  which  could  thus  be  used  as  a  marker 
enzyme. It is noteworthy that the specific activities 
of galactosyl transferase in both the purified Golgi 
fraction (0.4-0.6  /zmol galactose transferred  per 
milligram protein per 45  min) and the mast cell 
homogenate (approx. 0.012/zmol galactose trans- 
ferred  per  milligram  protein  per  45  min)  were 
higher  than  the  values  reported  for liver  Golgi 
fractions  (0.03-0.24  /~mol/mg  protein/h  [1,  6, 
10]) or liver homogenates (0.0017-0.0022/zmol/ 
mg protein/h  [1,  6]).  If it  is  assumed  that  liver 
3,000 
2,000 
t ,OOC 
FIGURE 9 
I  I  I 
5  tO  15 
N-ACETYLGLUCOSAMINE  EMx I0"3.1 
Effect of orosomucoid on the incorporation 
of [~4C]galactose into N-acetyllactosamine. Incubation 
and assay were as described in Fig. 4 with MES buffer, 
MnCIz, Triton  X-100,  UDP[14C]galactose, and  Golgi 
fraction plus N-acetylglucosamine as indicated with or 
without orosomucoid. Incorporation into N-acetyllacto- 
samine without orosomucoid, m, with 2 mg/ml orosomu- 
coid, D, incorporation into orosomucoid, ￿9 
Golgi fractions are  derived  mainly from hepatic 
parenchymal cells,  then our results might indicate 
that the Golgi apparatus of neoplastic mast cells 
may have a significantly higher galactosyl transfer- 
ase activity than the Golgi apparatus of liver pa- 
renchymal cells. However, the comparison may be 
misleading, since many of the reported assays for 
liver galactosyl transferase  have been performed 
at inhibitory concentrations of MnCI~ or acceptor 
while our assays were performed at optimal con- 
centrations. 
The 5'-nucleotidase enrichment in the mast cell 
Golgi fractions was greater  than  the  enrichment 
reported  for liver  Golgi fractions (2).  However, 
the actual specific activity of our Golgi preparation 
(-  0.19  /~mol/mg  protein/45  min)  was  only  a 
fraction of that reported for liver Golgi prepara- 
tions  (1.5-6  /zmol/mg protein/h  [1,  2,  10])  and 
was insignificant in comparison to values for liver 
plasma membranes (ca. 40/xmoles per mg protein 
per hr: ref. 2). 
Although  galactosyl  transferase  has  been  de- 
scribed  in  Golgi  fractions  isolated  from  several 
tissue sources (5-7, 10, 11, 19, 20, 24), generally, 
a single galactose acceptor has been used and no 
systematic investigations of the galactosyl transfer- 
ase activity have been performed. For this reason, 
it has not been demonstrated previously whether 
this enzymatic activity is present within the organ- 
elle  as a family of galactosyl transferases  or as a 
single  enzyme.  Studies  on galactosyl transferase 
from milk have indicated that a single  enzyme is 
involved (21).  It now appears  from the  present 
inhibition studies that in the mast cell Golgi appa- 
ratus,  a single  enzyme transfers galactose to two 
different  N-acetylglucosamine-containing  glyco- 
protein  acceptors  and  to  free  N-acetylglucosa- 
mine. 
The  galactosyl transferase  of Golgi  apparatus 
isolated  from  neoplastic  mast  cells  is  strikingly 
similar  to  galactosyl  transferase  isolated  from 
other tissues.  Included in the similarities  are pH 
TABLE II 
Competition Studies  With Glycoprotein Acceptors 
Acceptors  Galactosyl transferase activity* 
cpm  tunollrag protein145 rain 
Orosomucoid (2 mg/ml)  930  0.25 
Ovalbumin (20 mg/ml)  750  0.19 
Orosomucoid (2 mg/mi) + ovalbumin (20 mg/ml)  910  0.24 
* Incubation mixtures were similar to those described in Figure 4. Incorporations represent assay of 0.005-ml aliquots 
after 45-rain incubations. 
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22,  24), inhibition by higher manganese concen- 
trations  (17,  22),  and  substrate  inhibition (17, 
23). In particular, the concentrations of N-acetyl- 
glucosamine and orosomucoid that produce  sub- 
strate  inhibition in  our  experiments  are  almost 
identical to those described for liver Golgi prepa- 
rations (23). 
The  purified  galactosyl  transferase  from  milk 
and mammary gland has been examined in detail 
(17) and the complex kinetics have been shown to 
involve such phenomena as substrate and cofactor 
stimulations and inhibitions. An ordered sequence 
of cofactor addition has been proposed,  and sub- 
strate  inhibition  by  N-acetylglucosamine  is 
thought to be caused by its binding to the enzyme 
at  high  concentrations  without  a  concomitant 
binding of manganese to the enzyme. Protection 
against substrate inhibition with high manganese 
concentrations in  our  experiments  might  be  re- 
lated,  in  that  manganese  at  high  concentration 
might effectively compete with substrates to allow 
ordered incorporation to occur. Alternatively, our 
results might suggest that higher concentrations of 
substrates  could  be  effectively  removing  man- 
ganese, resulting in a decreased galactose incorpo- 
ration.  This could  then be  overcome  in part  by 
higher manganese concentrations. 
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